$8.58
0.283.37%
At close: Jul 20, 5:00 PM EST
$8.58
0.283.37%
Pre-Market: 5:08 AM EST
Puma Biotechnology Inc Stock Guidance
PBYINASDAQ
Puma Biotechnology (PBYI) last issued guidance on May 7, 2026 for Q2 2026. The company guided revenue in the range of $52.00M - $55.00M for the period.
Compared to prior guidance, Puma Biotechnology lowered its revenue forecast from a prior range of $222.00M - $229.00M.
Puma Biotechnology has issued 28 guidance updates between March 2, 2023 and May 7, 2026. During this period, the company raised its outlook 8 times and lowered it 13 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 7, 2026
Guidance Period
Q2 2026
Revenue Guidance Range
$52.00M - $55.00M
Puma Biotechnology Guidance History
Review all historical guidance issued by Puma Biotechnology, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Puma Biotechnology (PBYI)?
The most recent guidance for Puma Biotechnology (PBYI) was reported on May 7, 2026 for Q2 2026. Puma Biotechnology forecasted revenue between $52.00M and $55.00M for the period.
What revenue range did Puma Biotechnology (PBYI) guide for?
Puma Biotechnology (PBYI) guided revenue in the range of $52.00M to $55.00M for Q2 2026.
Did Puma Biotechnology (PBYI) raise or lower guidance?
Puma Biotechnology (PBYI) lowered its revenue guidance from a prior range of $222.00M - $229.00M to $52.00M - $55.00M for Q2 2026.
When did Puma Biotechnology (PBYI) last issue guidance?
Puma Biotechnology (PBYI) last issued guidance on May 7, 2026 for Q2 2026.
